abstract |
The present invention relates to 1,4-Oxazepines of formula I having inhibitory activity of BACE1 and / or BACE2, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and / or prophylactic treatment of, for example, Alzheimer's disease and type 2 diabetes. |